VTVT
vTv Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$135.51M
P/E Ratio
—
EPS
$-0.78
Beta
0.26
52W High
$44.00
52W Low
$14.00
50-Day MA
$35.72
200-Day MA
$29.95
Dividend Yield
—
Profit Margin
6.11%
Forward P/E
—
PEG Ratio
0.00
About vTv Therapeutics Inc
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet unmet medical needs.
Fundamentals
| Revenue (TTM) | $36.84M |
| Gross Profit (TTM) | $12.83M |
| EBITDA | $-3.03M |
| Operating Margin | 63.10% |
| Return on Equity | -1.48% |
| Return on Assets | -2.91% |
| Revenue/Share (TTM) | $3.73 |
| Book Value | $5.19 |
| Price-to-Book | 1.49 |
| Price-to-Sales (TTM) | 3.68 |
| EV/Revenue | 0.98 |
| EV/EBITDA | -2.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $3.94M |
| Float | $2.40M |
| % Insiders | 38.98% |
| % Institutions | 38.35% |
Historical Volatility
HV 10-Day
115.19%
HV 20-Day
96.85%
HV 30-Day
94.71%
HV 60-Day
82.17%
HV Rank
87.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($53.00 target)
6
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026